Use of an Additional Updated 2023–2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
Lakshmi Panagiotakopoulos(Centers for Disease Control and Prevention), Megan Wallace(Centers for Disease Control and Prevention), Danielle Moulia(Centers for Disease Control and Prevention), Oliver Brooks, Ruth Link‐Gelles(Centers for Disease Control and Prevention), Katherine E. Fleming-Dutra(Centers for Disease Control and Prevention), Kevin Chatham‐Stephens(National Center for Emerging and Zoonotic Infectious Diseases), Monica Godfrey, Christopher A. Taylor(Centers for Disease Control and Prevention), Matthew F. Daley(Kaiser Permanente)
Cited by 31
Related Papers
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011
|JAMA|2016|1.8k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Core Elements of Outpatient Antibiotic Stewardship
|MMWR Recommendations and Reports|2016|599
Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019
|MMWR Morbidity and Mortality Weekly Report|2019|265